Lilly Broadens Gene Therapy Push With Adverum Acquisition

 
• By Alaric DeArment
  
Lilly is acquiring gene therapy developer Adverum Biotechnologies. (Shutterstock)

More from Gene Therapies

More from Advanced Therapies